Drug recall · September 2, 2015
ADRUCIL recall
Why: Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).
- Lots / codes
Lot # 31317857B, Exp 08/15 31317859B, Exp 12/15 31317920B, Exp 12/15 31317957B, Exp 12/15 31318136B, Exp 12/15 31318138B, Exp 12/15
- Quantity
- 6001 vials
- Company
- Teva Pharmaceuticals USA, Horsham, PA
- Distribution
- Nationwide.
- Initiated
- July 24, 2015 · Voluntary: Firm initiated
- Classified
- August 24, 2015
- Reported
- September 2, 2015
- Ended
- November 2, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluorouracil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.